Viewing Study NCT06733233

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-02-10 @ 7:18 PM
Study NCT ID: NCT06733233
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-12-13
First Post: 2024-12-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer
Sponsor: Guangzhou Women and Children's Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer, Estrogen Receptor-Positive View
None HER2 Low Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast cancer View
None immunotherapy View
None DS8201 View
None Neoadjuvant View